Presumptive screening and definitive LC-MS/MS confirmation with custom panels, specimen-validity testing, and clinical interpretation support.
HealthQuest provides medication-monitoring and toxicology programs designed around your patient population — presumptive immunoassay screening, definitive LC-MS/MS confirmation, specimen-validity testing, and access to clinical consultation for interpretation questions. Panels are configurable to the medications and risk profiles your program manages.
Immunoassay for presumptive screening; liquid chromatography–tandem mass spectrometry (LC-MS/MS) for definitive identification and quantification, with isomer differentiation where clinically relevant.
Presumptive screens are typically reported within 24 hours; definitive confirmations within 48–72 hours of receipt.
Presumptive immunoassay screening provides rapid, cost-effective first-line results. When a result will inform a clinical decision — or does not match the clinical picture — definitive confirmation by LC-MS/MS identifies and quantifies specific drugs and metabolites, differentiates isomers where clinically relevant, and minimizes false positives from cross-reactivity.
Every urine toxicology specimen can include validity testing — creatinine, pH, and oxidant screening — to detect dilution, substitution, and adulteration. Oral fluid collections are observed, reducing substitution risk.
Providers order through the HealthQuest provider portal, by EMR/LIS integration, or by requisition. Panels are configured to your program's medication list and risk profile during onboarding, and our clinical team is available for interpretation questions on confirmed results.
Should presumptive positives be confirmed?
When results inform clinical decisions, definitive confirmation by LC-MS/MS is recommended — immunoassays can cross-react with unrelated compounds. Our team can help design a screen-plus-confirm protocol for your program.
Can you build a panel around our formulary?
Yes. Custom panels are a core part of our toxicology program. Contact our toxicology team to map panels to the medications and risk profile of your patient population.